Skip to Content
Explore our new website! Designed to better serve patients, partners and the Crinetics community in the next generation of endocrinology care.

News & Events

Show:

ENDO 2021

Event Date: March 20–23, 2021

READ MORE

Lead ACTH Antagonist CRN04894 (Cushing’s, CAH) Enters Phase 1 Study

This study will assess the safety and tolerability of single and multiple doses of CRN04894 and will measure the effect...

READ MORE

CRN04777 (Congenital Hyperinsulinism) Advances to Phase 1 Study

Phase 1 study of CRN04777, an oral, nonpeptide somatostatin receptor type 5 (SST5) agonist being developed as a treatment for...

READ MORE

10th Annual SVB Leerink Global Healthcare Conference

Event Date: February 24–26, 2021

READ MORE

Crinetics Update 39th Annual J.P. Morgan Healthcare Conference

Webcast: Crinetics Pharmaceuticals’ Founder and CEO, Scott Struthers provides 2020 review and 2021 Plans at 39th Annual JP Morgan Healthcare...

READ MORE

Crinetics Announces 2021 Plans at J.P. Morgan Healthcare Conference

Scott Struthers, Ph.D., Founder & CEO of Crinetics, presented 2020 update and 2021 plans. Live webcast of the presentation may be...

READ MORE

39th Annual J.P. Morgan Healthcare Conference

Event Date: January 11–14, 2021

READ MORE

Podcast: Work Continues on New Drugs/Therapies for Pituitary Patients

We wondered how this critically important work for pituitary patients was affected by the pandemic. Dr. Struthers gives us an...

READ MORE

Evercore ISI 3rd Annual HealthCONx Virtual Conference

Event Date: December 3, 2020

READ MORE

Crinetics Pharmaceuticals to Participate in December Investor Conferences

Dr. Scott Struthers and Dr. Alan Krasner present at 32nd annual Piper Sandler Healthcare Conference December 1st-3rd, 2020 Webcast available until...

READ MORE